[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Kwiatkowski et al., 2018 - Google Patents

Biosynthesis of carnosine and related dipeptides in vertebrates

Kwiatkowski et al., 2018

Document ID
9442684170012653125
Author
Kwiatkowski S
Kiersztan A
Drozak J
Publication year
Publication venue
Current Protein and Peptide Science

External Links

Snippet

Carnosine (β-alanyl-L-histidine) and its methylated derivatives: anserine (β-alanyl-Nπ- methyl-L-histidine) and balenine (β-alanyl-NΤ-methyl-L-histidine) are abundant constituents of excitable tissues of vertebrates. While carnosine and anserine are present at high …
Continue reading at www.ingentaconnect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Kwiatkowski et al. Biosynthesis of carnosine and related dipeptides in vertebrates
Nemkov et al. Hypoxia modulates the purine salvage pathway and decreases red blood cell and supernatant levels of hypoxanthine during refrigerated storage
Jakubowski Molecular basis of homocysteine toxicity in humans
Aldini et al. The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats
Mao et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation
Ryan et al. Post-translational oxidative modification and inactivation of mitochondrial complex I in epileptogenesis
Delgado-Reyes et al. Immunohistochemical detection of betaine–homocysteine S-methyltransferase in human, pig, and rat liver and kidney
Lorin et al. Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects
Baba et al. Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates
Liu et al. Contribution of nitric oxide and protein S-nitrosylation to variation in fresh meat quality
Oppici et al. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine: glyoxylate aminotransferase causing primary hyperoxaluria type I
Nath et al. Metallothioneins, oxidative stress and the cardiovascular system
Penafiel et al. Gender-related differences in carnosine, anserine and lysine content of murine skeletal muscle
Xie et al. Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications
Drozak et al. UPF0586 protein C9orf41 homolog is anserine-producing methyltransferase
Peters et al. Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency
Lapko et al. Methylation and carbamylation of human γ‐crystallins
Turner et al. Anti-cancer actions of carnosine and the restoration of normal cellular homeostasis
Mohanraj et al. Mitochondrial control of cellular protein homeostasis
Babizhayev et al. Skin beautification with oral non-hydrolized versions of carnosine and carcinine: Effective therapeutic management and cosmetic skincare solutions against oxidative glycation and free-radical production as a causal mechanism of diabetic complications and skin aging
Hu et al. Divergent developmental expression and function of the proton‐coupled oligopeptide transporters PepT2 and PhT1 in regional brain slices of mouse and rat
Sun et al. Methamphetamine produces cardiac damage and apoptosis by decreasing melusin
Valastro et al. Proteomic analysis of striatal proteins in the rat model of L‐DOPA‐induced dyskinesia
Li et al. Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase ζ1
Ye et al. O‐GlcNAcylation: cellular physiology and therapeutic target for human diseases